These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7779175)

  • 1. Access to specialty care.
    Kassirer JP
    N Engl J Med; 1994 Oct; 331(17):1151-3. PubMed ID: 7779175
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to specialty care.
    Zink TK
    N Engl J Med; 1995 Feb; 332(7):475; author reply 475-6. PubMed ID: 7824034
    [No Abstract]   [Full Text] [Related]  

  • 3. Specialty care works hard to assure its resurgence.
    Diamond F
    Manag Care; 2003 Aug; 12(8):18-23. PubMed ID: 12966846
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct access to specialists not necessarily more expensive.
    Capitation Rates Data; 2001 Feb; 6(2):15-7. PubMed ID: 11263423
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to specialty care and medical services in community health centers.
    Cook NL; Hicks LS; O'Malley AJ; Keegan T; Guadagnoli E; Landon BE
    Health Aff (Millwood); 2007; 26(5):1459-68. PubMed ID: 17848458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy: a review of the literature on streptokinase and tissue plasminogen activator with implications for practice.
    Brewer-Senerchia C
    Crit Care Nurs Clin North Am; 1989 Jun; 1(2):359-71. PubMed ID: 2510771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to specialty care.
    Diamond C
    N Engl J Med; 1995 Feb; 332(7):474; author reply 475-6. PubMed ID: 7824030
    [No Abstract]   [Full Text] [Related]  

  • 8. Specialty hospitals: their impact and their long-term viability.
    Smith RE
    J Okla State Med Assoc; 2004 Nov; 97(11):492-6. PubMed ID: 15609496
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
    Lessler DS; Avins AL
    Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public policy. A doctor's perspective.
    Hirschhorn K
    Mt Sinai J Med; 1997 Mar; 64(2):105-7. PubMed ID: 9057467
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Canadian Consensus Conference on Coronary Thrombolysis--current aspects].
    Cairns J; Armstrong P; Belenkie I; Hirsh J; Johnstone D; Knudtson M; Lemieux M; Massel D; Naylor D; Roy L
    Can J Cardiol; 1995; 11(7):581-6. PubMed ID: 7656193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical monopolies--a choice between quality and equality?].
    Rasmussen K; Bratlid D
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2980-3. PubMed ID: 16276386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy for acute myocardial infarction.
    Haley FL
    J Tenn Med Assoc; 1989 Apr; 82(4):183-6. PubMed ID: 2497271
    [No Abstract]   [Full Text] [Related]  

  • 16. Health care delivery problems and goals: a personal philosophic appraisal.
    Safar P
    Clin Anesth; 1974; 10(3):1-32. PubMed ID: 4613513
    [No Abstract]   [Full Text] [Related]  

  • 17. A crisis in chronic pain care: an ethical analysis. Part three: Toward an integrative, multi-disciplinary pain medicine built around the needs of the patient.
    Giordano J; Schatman ME
    Pain Physician; 2008; 11(6):775-84. PubMed ID: 19057625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of the gatekeeper. Some organizations are finding ways to modify the "gatekeeper" role and meet the public's demand for increased access.
    Nilson JT
    Healthc Exec; 1998; 13(4):18-22. PubMed ID: 10181096
    [No Abstract]   [Full Text] [Related]  

  • 20. Do specialist self-referral insurance policies improve access to HIV-experienced physicians as a regular source of care?
    Heslin KC; Andersen RM; Ettner SL; Kominski GF; Belin TR; Morgenstern H; Cunningham WE
    Med Care Res Rev; 2005 Oct; 62(5):583-600. PubMed ID: 16177459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.